iso 10993-3: biological evaluation of medical devices - tests for genotoxicity, carcinogenicity and...
TRANSCRIPT
ISO 10993-3
Biological evaluation of medical devices –
Tests for genotoxicity, carcinogenicity and
reproductive toxicity
Melissa Cadaret, MS
Director, Biocompatibility
NAMSA
1
2
ISO 10993-3 specifies strategies for
hazard identification and tests on medical
devices.
3
ISO 10993-3 specifies strategies for
hazard identification and tests on medical
devices.
Genotoxicity
4
ISO 10993-3 specifies strategies for
hazard identification and tests on medical
devices.
Genotoxicity
Carcinogenicity
5
ISO 10993-3 specifies strategies for
hazard identification and tests on medical
devices.
Genotoxicity
Carcinogenicity
Reproductive and Developmental Toxicity
6
Genotoxicity
7
Genotoxicity
These types of tests are designed to detect
two major classes of genetic damage
8
Genotoxicity
These types of tests are designed to detect
two major classes of genetic damage:
Gene Mutation
9
Genotoxicity
These types of tests are designed to detect
two major classes of genetic damage:
Gene Mutation
Chromosomal damage
10
Genotoxicity
There is no single test capable of detecting
all relevant genotoxic agents; therefore, the
usual approach is a testing battery.
11
Genotoxicity
Test Battery
Test for gene mutation in bacteria
12
Genotoxicity
Test Battery
Test for gene mutation in bacteria
And either
In vitro mammalian test with cytogenetic
evaluation of chromosomal damage
13
Genotoxicity
Test Battery
Test for gene mutation in bacteria
And either
In vitro mammalian test with cytogenetic
evaluation of chromosomal damage
Or
In vitro mouse lymphoma tk assay
14
Genotoxicity
Test Battery
Test for gene mutation in bacteria
And either
In vitro mammalian test with cytogenetic
evaluation of chromosomal damage
Or
In vitro mouse lymphoma tk assay
Or
In vitro mammalian cell micronucleus test
for chromosomal damage
15
Carcinogenicity
16
Carcinogenicity
These types of tests assess tumorigenic
potential
17
Carcinogenicity
This testing is required
When carcinogenic risk cannot be ruled
by risk analysis
18
Carcinogenicity
This testing is required
When carcinogenic risk cannot be ruled
by risk analysis
For materials which degradation time is
greater than 30 days
19
Carcinogenicity
This testing is required
When carcinogenic risk cannot be ruled
by risk analysis
For materials which degradation time is
greater than 30 days
For devices introduced in the
body/cavities with a permanent or
cumulative contact of greater than 30
days.
20
Reproductive and Developmental Toxicity
21
Reproductive and Developmental Toxicity
These tests evaluate the effects on
reproductive function, teratogenicity.
22
Reproductive and Developmental Toxicity
Requirement for testing is limited to certain
devices
23
Reproductive and Developmental Toxicity
Requirement for testing is limited to certain
devices
IUDs, or other devices in long-term
contact with reproductive tissues or
embryo/fetus
24
Reproductive and Developmental Toxicity
Requirement for testing is limited to certain
devices
IUDs, or other devices in long-term
contact with reproductive tissues or
embryo/fetus
Energy depositing devices
25
Reproductive and Developmental Toxicity
Requirement for testing is limited to certain
devices
IUDs, or other devices in long-term
contact with reproductive tissues or
embryo/fetus
Energy depositing devices
Resorbable or leachable material/devices
without adequate reproductive toxicity
data
26
To view the complete presentation on ISO 10993-3
Check out NAMSA’s Seminars
You can view the entire ISO 10993 Series here
For information about the services NAMSA can offer you regarding genotoxicity, carcinogenicity and reproductive toxicity
Visit our Biocompatibility page, or
Download our Biocompatibility brochure
For additional information
Contact us at [email protected].